Goldman Sachs Starts Karuna Therapeutics Inc. (KRTX) at Buy
Tweet
Share
E-mailGet Alerts KRTX Hot Sheet
Price: $329.83 --0%
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Rating Summary:
8 Buy, 16 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 17 | Down: 14 | New: 17
Join SI Premium – FREE
Goldman Sachs analyst Salveen Richter initiates coverage on Karuna Therapeutics Inc. (NASDAQ: KRTX) with a Buy rating and a price target of $34.00.
For an analyst ratings summary and ratings history on Karuna Therapeutics Inc. click here. For more ratings news on Karuna Therapeutics Inc. click here.
Shares of Karuna Therapeutics Inc. closed at $19.74 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- B.Riley Starts Energy Fuels (UUUU) at Buy
- Goldman Sachs First Take on Netflix (NFLX): 'We expect the market to have a muted reaction'
- CLSA Starts ASM Pacific Technology (522:HK) (ASMVY) at Outperform (2)
Create E-mail Alert Related Categories
New CoverageRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
